Target intelligence / Profile preview

Fatty acyl-coenzyme A desaturase

Molecular classification
Enzyme, Oxidoreductase, Desaturase family
01

Overview

Fatty acyl-coenzyme A desaturases are a family of enzymes that catalyze the introduction of *cis*-double bonds at specific positions within saturated fatty acyl-CoA substrates. The most studied member is Δ9-fatty acid desaturase—also known as stearoyl-CoA desaturase—which introduces a double bond at the ninth carbon from the carboxyl end. These enzymes play an essential role in producing monounsaturated and polyunsaturated fatty acids that are critical components for cell membranes and precursors for various complex lipids. Their activity influences cellular membrane properties, signaling pathways, and overall lipid metabolism. Dysregulation has been linked to several diseases including cancer, cardiovascular disease, obesity, and diabetes due to their central role in maintaining lipid homeostasis.

Other names
Fatty acid desaturaseAcyl-CoA desaturaseΔ9-fatty acid desaturase (for the most common subtype)Stearoyl-CoA desaturase (SCD, for a well-studied member)FADS1FADS2SCD1 (gene/protein family members)
02

Mechanism of action

Inhibition or modulation of enzymatic activity to alter unsaturated fatty acid levels.

03

Biological functions

Introduction of double bonds into fatty acyl chains of coenzyme A derivativesBiosynthesis of unsaturated and polyunsaturated fatty acidsRegulation of membrane fluidity and functionPrecursor synthesis for phospholipids, triacylglycerols, cholesteryl esters, wax esters
04

Disease associations

Cancer (altered lipid metabolism is implicated in tumorigenesis)Cardiovascular disease (impacts lipid profiles and membrane composition)Metabolic disorders such as obesity and diabetes (due to roles in lipid biosynthesis)
05

Safety considerations

Potential safety concerns could include disruption of essential fatty acid homeostasis leading to membrane dysfunction or metabolic imbalance.
06

Biomarkers

Altered expression or activity may serve as a biomarker for metabolic diseases or cancer progression.

Beyond the preview

Go deeper on Fatty acyl-coenzyme A desaturase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fatty acyl-coenzyme A desaturase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call